Evolus, Inc. (EOLS) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $279 million, Evolus, Inc. is a micro-cap company. The stock currently trades at $4.34, up 1.05% today, with a 52-week range of $4.09–$14.94.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.81 | $-0.81 | +25.0% | |
| 2023 | $-1.08 | $-1.08 | +18.8% | |
| 2022 | $-1.33 | $-1.33 | -41.5% | |
| 2021 | $-0.94 | $-0.94 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-04 | 0001570562-25-000020 | SEC ↗ |
| 2023-12-31 | 2024-03-07 | 0001570562-24-000041 | SEC ↗ |
| 2022-12-31 | 2023-03-08 | 0001570562-23-000038 | SEC ↗ |
| 2021-12-31 | 2022-03-03 | 0001570562-22-000067 | SEC ↗ |
| 2020-12-31 | 2021-03-25 | 0001570562-21-000093 | SEC ↗ |
| 2019-12-31 | 2020-02-25 | 0001570562-20-000061 | SEC ↗ |
| 2018-12-31 | 2019-03-20 | 0001570562-19-000038 | SEC ↗ |
| 2017-12-31 | 2018-03-29 | 0001570562-18-000013 | SEC ↗ |